# K062901: Hemocath II

- Pathway: 510(k) (Traditional)
- Applicant: Med-Conduit, Inc.
- Decided: Feb 8, 2007 after 134 days
- Product code: MSD (Catheter, Hemodialysis, Implanted)
- Device class: 2
- Regulation: 21 CFR 876.5540
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 4 generations back to K013160 (2002). 6 ancestors in all.
2 later devices descend from it; 1 cites it directly.
0 of 9 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K043292: Hemocath, Med-Conduit, Inc. (2005) Summary page 1.

## Most influential descendants
- K071202: Dermaport Percutaneous Vascular Access System (Pvas) (2007), 1 descendant of its own
- K091760: Dermaport Ported Vascular Access System (Pvas) (2009), 0 descendants of its own

## Indications for use
The HemoCath Hemodialysis/Apheresis Catheter is indicated for use in attaining long term vascular access for hemodialysis or apheresis therapy via the jugular or subclavian vein. The catheter is intended for implantation dwell time of greater than 30 days.

Source page: https://510kreport.com/device/K062901
Methodology: https://510kreport.com/methodology